Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study

OBJECTIVE: To evaluate the outcome and safety of the paclitaxel, carboplatin, and capecitabine (TCX) regimen in patients with advanced gastric cancer. METHODS: Advanced gastric cancer patients received the TCX regimen for up to six cycles, which were 3 weeks apart. Paclitaxel (175 mg/m2) was given o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hieu Trong, Do, Kien Hung, Le, Nguyen Ba, Tran, Thang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507975/
https://www.ncbi.nlm.nih.gov/pubmed/36164467
http://dx.doi.org/10.2147/CMAR.S384325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507975/
https://www.ncbi.nlm.nih.gov/pubmed/36164467
http://dx.doi.org/10.2147/CMAR.S384325

Ejemplares similares